nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—CYP2C8—Omeprazole—Barrett's esophagus	0.284	0.478	CbGbCtD
Trametinib—CYP3A4—Esomeprazole—Barrett's esophagus	0.196	0.329	CbGbCtD
Trametinib—CYP3A4—Omeprazole—Barrett's esophagus	0.115	0.194	CbGbCtD
Trametinib—MAP2K1—epithelium—Barrett's esophagus	0.0078	0.227	CbGeAlD
Trametinib—MAP2K1—smooth muscle tissue—Barrett's esophagus	0.00751	0.219	CbGeAlD
Trametinib—MAP2K2—smooth muscle tissue—Barrett's esophagus	0.00661	0.193	CbGeAlD
Trametinib—MAP2K1—digestive system—Barrett's esophagus	0.00593	0.173	CbGeAlD
Trametinib—Polyp—Omeprazole—Barrett's esophagus	0.00523	0.019	CcSEcCtD
Trametinib—Polyp—Esomeprazole—Barrett's esophagus	0.00523	0.019	CcSEcCtD
Trametinib—MAP2K2—digestive system—Barrett's esophagus	0.00522	0.152	CbGeAlD
Trametinib—Hypomagnesaemia—Esomeprazole—Barrett's esophagus	0.00501	0.0182	CcSEcCtD
Trametinib—Hypomagnesaemia—Omeprazole—Barrett's esophagus	0.00501	0.0182	CcSEcCtD
Trametinib—Cyst—Omeprazole—Barrett's esophagus	0.00476	0.0173	CcSEcCtD
Trametinib—Cyst—Esomeprazole—Barrett's esophagus	0.00476	0.0173	CcSEcCtD
Trametinib—Rash erythematous—Esomeprazole—Barrett's esophagus	0.00416	0.0151	CcSEcCtD
Trametinib—Rash erythematous—Omeprazole—Barrett's esophagus	0.00416	0.0151	CcSEcCtD
Trametinib—Bone disorder—Omeprazole—Barrett's esophagus	0.00352	0.0128	CcSEcCtD
Trametinib—Bone disorder—Esomeprazole—Barrett's esophagus	0.00352	0.0128	CcSEcCtD
Trametinib—Hyperbilirubinaemia—Omeprazole—Barrett's esophagus	0.0035	0.0127	CcSEcCtD
Trametinib—Hyperbilirubinaemia—Esomeprazole—Barrett's esophagus	0.0035	0.0127	CcSEcCtD
Trametinib—Hypocalcaemia—Omeprazole—Barrett's esophagus	0.00348	0.0126	CcSEcCtD
Trametinib—Hypocalcaemia—Esomeprazole—Barrett's esophagus	0.00348	0.0126	CcSEcCtD
Trametinib—Creatinine increased—Esomeprazole—Barrett's esophagus	0.00334	0.0121	CcSEcCtD
Trametinib—Creatinine increased—Omeprazole—Barrett's esophagus	0.00334	0.0121	CcSEcCtD
Trametinib—Phosphatase alkaline increased—Omeprazole—Barrett's esophagus	0.00318	0.0115	CcSEcCtD
Trametinib—Phosphatase alkaline increased—Esomeprazole—Barrett's esophagus	0.00318	0.0115	CcSEcCtD
Trametinib—Melaena—Esomeprazole—Barrett's esophagus	0.00311	0.0113	CcSEcCtD
Trametinib—Melaena—Omeprazole—Barrett's esophagus	0.00311	0.0113	CcSEcCtD
Trametinib—Dry eye—Omeprazole—Barrett's esophagus	0.00294	0.0107	CcSEcCtD
Trametinib—Dry eye—Esomeprazole—Barrett's esophagus	0.00294	0.0107	CcSEcCtD
Trametinib—Rash maculo-papular—Esomeprazole—Barrett's esophagus	0.00289	0.0105	CcSEcCtD
Trametinib—Rash maculo-papular—Omeprazole—Barrett's esophagus	0.00289	0.0105	CcSEcCtD
Trametinib—Neoplasm—Omeprazole—Barrett's esophagus	0.00288	0.0104	CcSEcCtD
Trametinib—Mouth ulceration—Esomeprazole—Barrett's esophagus	0.00288	0.0104	CcSEcCtD
Trametinib—Neoplasm—Esomeprazole—Barrett's esophagus	0.00288	0.0104	CcSEcCtD
Trametinib—Mouth ulceration—Omeprazole—Barrett's esophagus	0.00288	0.0104	CcSEcCtD
Trametinib—Blood alkaline phosphatase increased—Omeprazole—Barrett's esophagus	0.00266	0.00964	CcSEcCtD
Trametinib—Blood alkaline phosphatase increased—Esomeprazole—Barrett's esophagus	0.00266	0.00964	CcSEcCtD
Trametinib—Hyponatraemia—Omeprazole—Barrett's esophagus	0.00232	0.00842	CcSEcCtD
Trametinib—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.00232	0.00842	CcSEcCtD
Trametinib—Pain in extremity—Omeprazole—Barrett's esophagus	0.00231	0.00838	CcSEcCtD
Trametinib—Pain in extremity—Esomeprazole—Barrett's esophagus	0.00231	0.00838	CcSEcCtD
Trametinib—MAP2K1—Osteopontin Signaling—RELA—Barrett's esophagus	0.00225	0.0237	CbGpPWpGaD
Trametinib—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.00216	0.00785	CcSEcCtD
Trametinib—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.00216	0.00785	CcSEcCtD
Trametinib—Dry skin—Esomeprazole—Barrett's esophagus	0.00212	0.00768	CcSEcCtD
Trametinib—Dry skin—Omeprazole—Barrett's esophagus	0.00212	0.00768	CcSEcCtD
Trametinib—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.00211	0.00766	CcSEcCtD
Trametinib—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.00211	0.00766	CcSEcCtD
Trametinib—Hypokalaemia—Omeprazole—Barrett's esophagus	0.0021	0.00763	CcSEcCtD
Trametinib—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.0021	0.00763	CcSEcCtD
Trametinib—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.00208	0.00755	CcSEcCtD
Trametinib—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00208	0.00755	CcSEcCtD
Trametinib—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00204	0.00739	CcSEcCtD
Trametinib—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.00204	0.00739	CcSEcCtD
Trametinib—Pancreatitis—Esomeprazole—Barrett's esophagus	0.00196	0.0071	CcSEcCtD
Trametinib—Pancreatitis—Omeprazole—Barrett's esophagus	0.00196	0.0071	CcSEcCtD
Trametinib—MAP2K2—Signaling of Hepatocyte Growth Factor Receptor—HGF—Barrett's esophagus	0.00192	0.0202	CbGpPWpGaD
Trametinib—CYP2C8—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.00191	0.0201	CbGpPWpGaD
Trametinib—MAP2K2—BDNF signaling pathway—CRTC1—Barrett's esophagus	0.0019	0.02	CbGpPWpGaD
Trametinib—Neutropenia—Esomeprazole—Barrett's esophagus	0.00187	0.00677	CcSEcCtD
Trametinib—Neutropenia—Omeprazole—Barrett's esophagus	0.00187	0.00677	CcSEcCtD
Trametinib—MAP2K2—Endothelins—SLC9A1—Barrett's esophagus	0.00184	0.0194	CbGpPWpGaD
Trametinib—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00184	0.0194	CbGpPWpGaD
Trametinib—MAP2K1—Signaling of Hepatocyte Growth Factor Receptor—HGF—Barrett's esophagus	0.0018	0.0189	CbGpPWpGaD
Trametinib—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00178	0.00646	CcSEcCtD
Trametinib—Infestation—Omeprazole—Barrett's esophagus	0.00178	0.00646	CcSEcCtD
Trametinib—Infestation NOS—Omeprazole—Barrett's esophagus	0.00178	0.00646	CcSEcCtD
Trametinib—Infestation—Esomeprazole—Barrett's esophagus	0.00178	0.00646	CcSEcCtD
Trametinib—MAP2K1—BDNF signaling pathway—CRTC1—Barrett's esophagus	0.00178	0.0187	CbGpPWpGaD
Trametinib—Renal failure—Omeprazole—Barrett's esophagus	0.00175	0.00635	CcSEcCtD
Trametinib—Renal failure—Esomeprazole—Barrett's esophagus	0.00175	0.00635	CcSEcCtD
Trametinib—Stomatitis—Omeprazole—Barrett's esophagus	0.00174	0.0063	CcSEcCtD
Trametinib—Stomatitis—Esomeprazole—Barrett's esophagus	0.00174	0.0063	CcSEcCtD
Trametinib—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.00173	0.00628	CcSEcCtD
Trametinib—Urinary tract infection—Omeprazole—Barrett's esophagus	0.00173	0.00628	CcSEcCtD
Trametinib—MAP2K1—Endothelins—SLC9A1—Barrett's esophagus	0.00172	0.0181	CbGpPWpGaD
Trametinib—Haematuria—Omeprazole—Barrett's esophagus	0.0017	0.00616	CcSEcCtD
Trametinib—Haematuria—Esomeprazole—Barrett's esophagus	0.0017	0.00616	CcSEcCtD
Trametinib—Epistaxis—Omeprazole—Barrett's esophagus	0.00168	0.00609	CcSEcCtD
Trametinib—Epistaxis—Esomeprazole—Barrett's esophagus	0.00168	0.00609	CcSEcCtD
Trametinib—Bradycardia—Esomeprazole—Barrett's esophagus	0.00163	0.0059	CcSEcCtD
Trametinib—Bradycardia—Omeprazole—Barrett's esophagus	0.00163	0.0059	CcSEcCtD
Trametinib—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.00158	0.00573	CcSEcCtD
Trametinib—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.00158	0.00573	CcSEcCtD
Trametinib—Oedema peripheral—Omeprazole—Barrett's esophagus	0.00157	0.00571	CcSEcCtD
Trametinib—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.00157	0.00571	CcSEcCtD
Trametinib—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.00157	0.0057	CcSEcCtD
Trametinib—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.00157	0.0057	CcSEcCtD
Trametinib—Urethral disorder—Omeprazole—Barrett's esophagus	0.00157	0.00568	CcSEcCtD
Trametinib—Urethral disorder—Esomeprazole—Barrett's esophagus	0.00157	0.00568	CcSEcCtD
Trametinib—Eye disorder—Esomeprazole—Barrett's esophagus	0.00149	0.00542	CcSEcCtD
Trametinib—Eye disorder—Omeprazole—Barrett's esophagus	0.00149	0.00542	CcSEcCtD
Trametinib—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00144	0.00523	CcSEcCtD
Trametinib—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00144	0.00523	CcSEcCtD
Trametinib—Chills—Omeprazole—Barrett's esophagus	0.00143	0.0052	CcSEcCtD
Trametinib—Chills—Esomeprazole—Barrett's esophagus	0.00143	0.0052	CcSEcCtD
Trametinib—Mental disorder—Omeprazole—Barrett's esophagus	0.0014	0.00508	CcSEcCtD
Trametinib—Mental disorder—Esomeprazole—Barrett's esophagus	0.0014	0.00508	CcSEcCtD
Trametinib—Malnutrition—Omeprazole—Barrett's esophagus	0.00139	0.00505	CcSEcCtD
Trametinib—Malnutrition—Esomeprazole—Barrett's esophagus	0.00139	0.00505	CcSEcCtD
Trametinib—Dysgeusia—Omeprazole—Barrett's esophagus	0.00136	0.00494	CcSEcCtD
Trametinib—Dysgeusia—Esomeprazole—Barrett's esophagus	0.00136	0.00494	CcSEcCtD
Trametinib—Back pain—Omeprazole—Barrett's esophagus	0.00135	0.00488	CcSEcCtD
Trametinib—Back pain—Esomeprazole—Barrett's esophagus	0.00135	0.00488	CcSEcCtD
Trametinib—Muscle spasms—Omeprazole—Barrett's esophagus	0.00134	0.00485	CcSEcCtD
Trametinib—Muscle spasms—Esomeprazole—Barrett's esophagus	0.00134	0.00485	CcSEcCtD
Trametinib—Vision blurred—Esomeprazole—Barrett's esophagus	0.00131	0.00476	CcSEcCtD
Trametinib—Vision blurred—Omeprazole—Barrett's esophagus	0.00131	0.00476	CcSEcCtD
Trametinib—Anaemia—Omeprazole—Barrett's esophagus	0.00129	0.00467	CcSEcCtD
Trametinib—Anaemia—Esomeprazole—Barrett's esophagus	0.00129	0.00467	CcSEcCtD
Trametinib—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00125	0.0132	CbGpPWpGaD
Trametinib—MAP2K2—Bladder Cancer—CDKN2A—Barrett's esophagus	0.00125	0.0131	CbGpPWpGaD
Trametinib—Leukopenia—Esomeprazole—Barrett's esophagus	0.00125	0.00452	CcSEcCtD
Trametinib—Leukopenia—Omeprazole—Barrett's esophagus	0.00125	0.00452	CcSEcCtD
Trametinib—CYP2C8—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00123	0.013	CbGpPWpGaD
Trametinib—CYP3A4—digestive system—Barrett's esophagus	0.00122	0.0357	CbGeAlD
Trametinib—MAP2K2—ErbB1 downstream signaling—SLC9A1—Barrett's esophagus	0.00122	0.0129	CbGpPWpGaD
Trametinib—Cough—Omeprazole—Barrett's esophagus	0.00121	0.00441	CcSEcCtD
Trametinib—Cough—Esomeprazole—Barrett's esophagus	0.00121	0.00441	CcSEcCtD
Trametinib—Hypertension—Esomeprazole—Barrett's esophagus	0.0012	0.00436	CcSEcCtD
Trametinib—Hypertension—Omeprazole—Barrett's esophagus	0.0012	0.00436	CcSEcCtD
Trametinib—Arthralgia—Omeprazole—Barrett's esophagus	0.00118	0.0043	CcSEcCtD
Trametinib—Arthralgia—Esomeprazole—Barrett's esophagus	0.00118	0.0043	CcSEcCtD
Trametinib—Myalgia—Omeprazole—Barrett's esophagus	0.00118	0.0043	CcSEcCtD
Trametinib—Myalgia—Esomeprazole—Barrett's esophagus	0.00118	0.0043	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00118	0.00427	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00118	0.00427	CcSEcCtD
Trametinib—MAP2K1—Bladder Cancer—CDKN2A—Barrett's esophagus	0.00117	0.0123	CbGpPWpGaD
Trametinib—Dry mouth—Omeprazole—Barrett's esophagus	0.00116	0.0042	CcSEcCtD
Trametinib—Dry mouth—Esomeprazole—Barrett's esophagus	0.00116	0.0042	CcSEcCtD
Trametinib—MAP2K1—ErbB1 downstream signaling—SLC9A1—Barrett's esophagus	0.00114	0.0121	CbGpPWpGaD
Trametinib—MAP2K2—Bladder Cancer—CXCL8—Barrett's esophagus	0.00113	0.0119	CbGpPWpGaD
Trametinib—Infection—Omeprazole—Barrett's esophagus	0.00113	0.00409	CcSEcCtD
Trametinib—Infection—Esomeprazole—Barrett's esophagus	0.00113	0.00409	CcSEcCtD
Trametinib—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00111	0.00404	CcSEcCtD
Trametinib—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00111	0.00404	CcSEcCtD
Trametinib—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.00111	0.00403	CcSEcCtD
Trametinib—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.00111	0.00403	CcSEcCtD
Trametinib—Skin disorder—Esomeprazole—Barrett's esophagus	0.0011	0.004	CcSEcCtD
Trametinib—Skin disorder—Omeprazole—Barrett's esophagus	0.0011	0.004	CcSEcCtD
Trametinib—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.0011	0.00398	CcSEcCtD
Trametinib—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.0011	0.00398	CcSEcCtD
Trametinib—MAP2K1—Bladder Cancer—CXCL8—Barrett's esophagus	0.00106	0.0111	CbGpPWpGaD
Trametinib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00106	0.0111	CbGpPWpGaD
Trametinib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00106	0.0111	CbGpPWpGaD
Trametinib—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.00103	0.00375	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.00103	0.00375	CcSEcCtD
Trametinib—Insomnia—Esomeprazole—Barrett's esophagus	0.00103	0.00373	CcSEcCtD
Trametinib—Insomnia—Omeprazole—Barrett's esophagus	0.00103	0.00373	CcSEcCtD
Trametinib—CYP2C8—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00101	0.0107	CbGpPWpGaD
Trametinib—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000987	0.00358	CcSEcCtD
Trametinib—Decreased appetite—Omeprazole—Barrett's esophagus	0.000987	0.00358	CcSEcCtD
Trametinib—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000981	0.00356	CcSEcCtD
Trametinib—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000981	0.00356	CcSEcCtD
Trametinib—Fatigue—Omeprazole—Barrett's esophagus	0.000979	0.00355	CcSEcCtD
Trametinib—Fatigue—Esomeprazole—Barrett's esophagus	0.000979	0.00355	CcSEcCtD
Trametinib—Constipation—Omeprazole—Barrett's esophagus	0.000971	0.00352	CcSEcCtD
Trametinib—Constipation—Esomeprazole—Barrett's esophagus	0.000971	0.00352	CcSEcCtD
Trametinib—MAP2K2—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HGF—Barrett's esophagus	0.000968	0.0102	CbGpPWpGaD
Trametinib—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000929	0.00337	CcSEcCtD
Trametinib—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000929	0.00337	CcSEcCtD
Trametinib—MAP2K2—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000924	0.00974	CbGpPWpGaD
Trametinib—MAP2K1—FOXM1 transcription factor network—CDKN2A—Barrett's esophagus	0.000915	0.00964	CbGpPWpGaD
Trametinib—MAP2K2—Interleukin-11 Signaling Pathway—RELA—Barrett's esophagus	0.000906	0.00955	CbGpPWpGaD
Trametinib—MAP2K1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HGF—Barrett's esophagus	0.000906	0.00955	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000899	0.00947	CbGpPWpGaD
Trametinib—Body temperature increased—Omeprazole—Barrett's esophagus	0.000898	0.00326	CcSEcCtD
Trametinib—Abdominal pain—Omeprazole—Barrett's esophagus	0.000898	0.00326	CcSEcCtD
Trametinib—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000898	0.00326	CcSEcCtD
Trametinib—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000898	0.00326	CcSEcCtD
Trametinib—MAP2K1—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000865	0.00911	CbGpPWpGaD
Trametinib—MAP2K2—Structural Pathway of Interleukin 1 (IL-1)—RELA—Barrett's esophagus	0.00086	0.00906	CbGpPWpGaD
Trametinib—MAP2K2—TSLP Signaling Pathway—RELA—Barrett's esophagus	0.00086	0.00906	CbGpPWpGaD
Trametinib—MAP2K1—Interleukin-11 Signaling Pathway—RELA—Barrett's esophagus	0.000848	0.00894	CbGpPWpGaD
Trametinib—MAP2K2—Ceramide signaling pathway—RELA—Barrett's esophagus	0.000845	0.00891	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000841	0.00886	CbGpPWpGaD
Trametinib—MAP2K1—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000818	0.00862	CbGpPWpGaD
Trametinib—Asthenia—Esomeprazole—Barrett's esophagus	0.000815	0.00296	CcSEcCtD
Trametinib—Asthenia—Omeprazole—Barrett's esophagus	0.000815	0.00296	CcSEcCtD
Trametinib—MAP2K2—TSLP Signaling Pathway—CXCL8—Barrett's esophagus	0.00081	0.00854	CbGpPWpGaD
Trametinib—MAP2K1—Structural Pathway of Interleukin 1 (IL-1)—RELA—Barrett's esophagus	0.000804	0.00848	CbGpPWpGaD
Trametinib—MAP2K1—TSLP Signaling Pathway—RELA—Barrett's esophagus	0.000804	0.00848	CbGpPWpGaD
Trametinib—Pruritus—Omeprazole—Barrett's esophagus	0.000804	0.00291	CcSEcCtD
Trametinib—Pruritus—Esomeprazole—Barrett's esophagus	0.000804	0.00291	CcSEcCtD
Trametinib—MAP2K1—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	0.000795	0.00838	CbGpPWpGaD
Trametinib—MAP2K1—Ceramide signaling pathway—RELA—Barrett's esophagus	0.000791	0.00834	CbGpPWpGaD
Trametinib—Diarrhoea—Omeprazole—Barrett's esophagus	0.000777	0.00282	CcSEcCtD
Trametinib—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000777	0.00282	CcSEcCtD
Trametinib—MAP2K2—Signaling by Interleukins—HGF—Barrett's esophagus	0.000762	0.00803	CbGpPWpGaD
Trametinib—MAP2K2—IL-1 signaling pathway—RELA—Barrett's esophagus	0.000758	0.00799	CbGpPWpGaD
Trametinib—MAP2K1—TSLP Signaling Pathway—CXCL8—Barrett's esophagus	0.000758	0.00799	CbGpPWpGaD
Trametinib—Dizziness—Omeprazole—Barrett's esophagus	0.000751	0.00272	CcSEcCtD
Trametinib—Dizziness—Esomeprazole—Barrett's esophagus	0.000751	0.00272	CcSEcCtD
Trametinib—MAP2K1—IL-3 Signaling Pathway—CXCL8—Barrett's esophagus	0.000733	0.00773	CbGpPWpGaD
Trametinib—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000733	0.00772	CbGpPWpGaD
Trametinib—Vomiting—Esomeprazole—Barrett's esophagus	0.000722	0.00262	CcSEcCtD
Trametinib—Vomiting—Omeprazole—Barrett's esophagus	0.000722	0.00262	CcSEcCtD
Trametinib—MAP2K2—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—APC—Barrett's esophagus	0.000719	0.00758	CbGpPWpGaD
Trametinib—Rash—Omeprazole—Barrett's esophagus	0.000716	0.0026	CcSEcCtD
Trametinib—Rash—Esomeprazole—Barrett's esophagus	0.000716	0.0026	CcSEcCtD
Trametinib—Dermatitis—Esomeprazole—Barrett's esophagus	0.000715	0.0026	CcSEcCtD
Trametinib—Dermatitis—Omeprazole—Barrett's esophagus	0.000715	0.0026	CcSEcCtD
Trametinib—MAP2K1—Signaling by Interleukins—HGF—Barrett's esophagus	0.000713	0.00751	CbGpPWpGaD
Trametinib—Headache—Omeprazole—Barrett's esophagus	0.000712	0.00258	CcSEcCtD
Trametinib—Headache—Esomeprazole—Barrett's esophagus	0.000712	0.00258	CcSEcCtD
Trametinib—MAP2K1—RANKL/RANK Signaling Pathway—RELA—Barrett's esophagus	0.000709	0.00748	CbGpPWpGaD
Trametinib—MAP2K1—IL-1 signaling pathway—RELA—Barrett's esophagus	0.000709	0.00748	CbGpPWpGaD
Trametinib—MAP2K2—Fc-epsilon receptor I signaling in mast cells—RELA—Barrett's esophagus	0.000698	0.00735	CbGpPWpGaD
Trametinib—MAP2K2—Bladder Cancer—TP53—Barrett's esophagus	0.000694	0.00731	CbGpPWpGaD
Trametinib—Nausea—Omeprazole—Barrett's esophagus	0.000675	0.00245	CcSEcCtD
Trametinib—Nausea—Esomeprazole—Barrett's esophagus	0.000675	0.00245	CcSEcCtD
Trametinib—MAP2K1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—APC—Barrett's esophagus	0.000673	0.00709	CbGpPWpGaD
Trametinib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000671	0.00707	CbGpPWpGaD
Trametinib—MAP2K2—Oncostatin M Signaling Pathway—RELA—Barrett's esophagus	0.000663	0.00699	CbGpPWpGaD
Trametinib—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000662	0.00698	CbGpPWpGaD
Trametinib—MAP2K1—Fc-epsilon receptor I signaling in mast cells—RELA—Barrett's esophagus	0.000653	0.00688	CbGpPWpGaD
Trametinib—MAP2K1—Bladder Cancer—TP53—Barrett's esophagus	0.000649	0.00684	CbGpPWpGaD
Trametinib—MAP2K1—Oncostatin M Signaling Pathway—RELA—Barrett's esophagus	0.000621	0.00654	CbGpPWpGaD
Trametinib—MAP2K1—AGE/RAGE pathway—RELA—Barrett's esophagus	0.000613	0.00646	CbGpPWpGaD
Trametinib—MAP2K1—BCR signaling pathway—RELA—Barrett's esophagus	0.000606	0.00638	CbGpPWpGaD
Trametinib—MAP2K2—Leptin signaling pathway—RELA—Barrett's esophagus	0.000592	0.00623	CbGpPWpGaD
Trametinib—MAP2K2—TRAF6 Mediated Induction of proinflammatory cytokines—RELA—Barrett's esophagus	0.000592	0.00623	CbGpPWpGaD
Trametinib—MAP2K2—Amyotrophic lateral sclerosis (ALS)—TP53—Barrett's esophagus	0.000589	0.00621	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways in Glioblastoma—CDKN2A—Barrett's esophagus	0.000572	0.00603	CbGpPWpGaD
Trametinib—MAP2K1—TRAF6 Mediated Induction of proinflammatory cytokines—RELA—Barrett's esophagus	0.000554	0.00583	CbGpPWpGaD
Trametinib—MAP2K1—Leptin signaling pathway—RELA—Barrett's esophagus	0.000554	0.00583	CbGpPWpGaD
Trametinib—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000544	0.00573	CbGpPWpGaD
Trametinib—CYP2C8—Biological oxidations—CYP26A1—Barrett's esophagus	0.000538	0.00567	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways in Glioblastoma—CDKN2A—Barrett's esophagus	0.000536	0.00564	CbGpPWpGaD
Trametinib—MAP2K2—MyD88 cascade initiated on plasma membrane—RELA—Barrett's esophagus	0.000535	0.00564	CbGpPWpGaD
Trametinib—CYP2C8—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000531	0.00559	CbGpPWpGaD
Trametinib—MAP2K2—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RELA—Barrett's esophagus	0.00053	0.00559	CbGpPWpGaD
Trametinib—MAP2K2—MyD88 dependent cascade initiated on endosome—RELA—Barrett's esophagus	0.000521	0.00549	CbGpPWpGaD
Trametinib—MAP2K2—TCR Signaling Pathway—RELA—Barrett's esophagus	0.000511	0.00539	CbGpPWpGaD
Trametinib—MAP2K2—Toll Like Receptor 9 (TLR9) Cascade—RELA—Barrett's esophagus	0.000502	0.00529	CbGpPWpGaD
Trametinib—MAP2K1—MyD88 cascade initiated on plasma membrane—RELA—Barrett's esophagus	0.000501	0.00528	CbGpPWpGaD
Trametinib—MAP2K1—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RELA—Barrett's esophagus	0.000496	0.00523	CbGpPWpGaD
Trametinib—MAP2K2—MyD88:Mal cascade initiated on plasma membrane—RELA—Barrett's esophagus	0.000494	0.0052	CbGpPWpGaD
Trametinib—MAP2K1—MyD88 dependent cascade initiated on endosome—RELA—Barrett's esophagus	0.000487	0.00513	CbGpPWpGaD
Trametinib—MAP2K2—Focal Adhesion—HGF—Barrett's esophagus	0.000485	0.00511	CbGpPWpGaD
Trametinib—MAP2K2—B Cell Receptor Signaling Pathway—RELA—Barrett's esophagus	0.000482	0.00507	CbGpPWpGaD
Trametinib—MAP2K1—TCR Signaling Pathway—RELA—Barrett's esophagus	0.000478	0.00504	CbGpPWpGaD
Trametinib—MAP2K2—MyD88-independent cascade—RELA—Barrett's esophagus	0.000474	0.00499	CbGpPWpGaD
Trametinib—MAP2K1—Toll Like Receptor 9 (TLR9) Cascade—RELA—Barrett's esophagus	0.00047	0.00495	CbGpPWpGaD
Trametinib—MAP2K1—Corticotropin-releasing hormone—RELA—Barrett's esophagus	0.00047	0.00495	CbGpPWpGaD
Trametinib—MAP2K2—Toll-like Receptor Signaling Pathway—RELA—Barrett's esophagus	0.000463	0.00487	CbGpPWpGaD
Trametinib—MAP2K1—MyD88:Mal cascade initiated on plasma membrane—RELA—Barrett's esophagus	0.000462	0.00487	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—HGF—Barrett's esophagus	0.000454	0.00478	CbGpPWpGaD
Trametinib—MAP2K1—B Cell Receptor Signaling Pathway—RELA—Barrett's esophagus	0.000451	0.00475	CbGpPWpGaD
Trametinib—MAP2K2—BDNF signaling pathway—APC—Barrett's esophagus	0.000449	0.00473	CbGpPWpGaD
Trametinib—MAP2K1—MyD88-independent cascade—RELA—Barrett's esophagus	0.000443	0.00467	CbGpPWpGaD
Trametinib—MAP2K1—Corticotropin-releasing hormone—CXCL8—Barrett's esophagus	0.000443	0.00467	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by Interleukins—RELA—Barrett's esophagus	0.000442	0.00466	CbGpPWpGaD
Trametinib—MAP2K1—Senescence and Autophagy in Cancer—CDKN2A—Barrett's esophagus	0.000439	0.00463	CbGpPWpGaD
Trametinib—MAP2K2—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000437	0.00461	CbGpPWpGaD
Trametinib—MAP2K2—Toll-like Receptor Signaling Pathway—CXCL8—Barrett's esophagus	0.000436	0.00459	CbGpPWpGaD
Trametinib—MAP2K1—Toll-like Receptor Signaling Pathway—RELA—Barrett's esophagus	0.000433	0.00456	CbGpPWpGaD
Trametinib—MAP2K2—Activated TLR4 signalling—RELA—Barrett's esophagus	0.000426	0.00449	CbGpPWpGaD
Trametinib—MAP2K1—BDNF signaling pathway—APC—Barrett's esophagus	0.00042	0.00443	CbGpPWpGaD
Trametinib—MAP2K1—ErbB Signaling Pathway—TP53—Barrett's esophagus	0.000416	0.00439	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by Interleukins—RELA—Barrett's esophagus	0.000413	0.00436	CbGpPWpGaD
Trametinib—MAP2K1—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000409	0.00431	CbGpPWpGaD
Trametinib—MAP2K1—Toll-like Receptor Signaling Pathway—CXCL8—Barrett's esophagus	0.000408	0.0043	CbGpPWpGaD
Trametinib—MAP2K2—Toll Like Receptor 4 (TLR4) Cascade—RELA—Barrett's esophagus	0.000401	0.00422	CbGpPWpGaD
Trametinib—MAP2K1—Activated TLR4 signalling—RELA—Barrett's esophagus	0.000399	0.0042	CbGpPWpGaD
Trametinib—MAP2K1—Senescence and Autophagy in Cancer—CXCL8—Barrett's esophagus	0.000399	0.0042	CbGpPWpGaD
Trametinib—MAP2K2—Oncostatin M Signaling Pathway—TP53—Barrett's esophagus	0.000384	0.00404	CbGpPWpGaD
Trametinib—MAP2K1—Toll Like Receptor 4 (TLR4) Cascade—RELA—Barrett's esophagus	0.000375	0.00395	CbGpPWpGaD
Trametinib—CYP2C8—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000374	0.00394	CbGpPWpGaD
Trametinib—MAP2K2—Regulation of toll-like receptor signaling pathway—RELA—Barrett's esophagus	0.000361	0.00381	CbGpPWpGaD
Trametinib—MAP2K1—Oncostatin M Signaling Pathway—TP53—Barrett's esophagus	0.000359	0.00378	CbGpPWpGaD
Trametinib—MAP2K2—Toll-Like Receptors Cascades—RELA—Barrett's esophagus	0.000357	0.00376	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—HGF—Barrett's esophagus	0.000355	0.00375	CbGpPWpGaD
Trametinib—MAP2K2—BDNF signaling pathway—RELA—Barrett's esophagus	0.000351	0.0037	CbGpPWpGaD
Trametinib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000348	0.00366	CbGpPWpGaD
Trametinib—MAP2K2—Regulation of toll-like receptor signaling pathway—CXCL8—Barrett's esophagus	0.00034	0.00359	CbGpPWpGaD
Trametinib—MAP2K1—Regulation of toll-like receptor signaling pathway—RELA—Barrett's esophagus	0.000338	0.00356	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000335	0.00353	CbGpPWpGaD
Trametinib—MAP2K1—Toll-Like Receptors Cascades—RELA—Barrett's esophagus	0.000334	0.00352	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—HGF—Barrett's esophagus	0.000333	0.0035	CbGpPWpGaD
Trametinib—MAP2K1—BDNF signaling pathway—RELA—Barrett's esophagus	0.000328	0.00346	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways in Glioblastoma—TP53—Barrett's esophagus	0.000319	0.00336	CbGpPWpGaD
Trametinib—MAP2K1—Regulation of toll-like receptor signaling pathway—CXCL8—Barrett's esophagus	0.000318	0.00336	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways in Glioblastoma—TP53—Barrett's esophagus	0.000298	0.00314	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.000298	0.00314	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.000289	0.00304	CbGpPWpGaD
Trametinib—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000285	0.003	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.000278	0.00293	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000273	0.00287	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—GAST—Barrett's esophagus	0.00026	0.00274	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000255	0.00268	CbGpPWpGaD
Trametinib—MAP2K1—Senescence and Autophagy in Cancer—TP53—Barrett's esophagus	0.000245	0.00258	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—GAST—Barrett's esophagus	0.000243	0.00257	CbGpPWpGaD
Trametinib—MAP2K2—TGF-beta Signaling Pathway—TP53—Barrett's esophagus	0.000218	0.00229	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	0.000206	0.00217	CbGpPWpGaD
Trametinib—MAP2K1—TGF-beta Signaling Pathway—TP53—Barrett's esophagus	0.000204	0.00215	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—RELA—Barrett's esophagus	0.000203	0.00214	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	0.000193	0.00203	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—RELA—Barrett's esophagus	0.00019	0.002	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—TP53—Barrett's esophagus	0.000179	0.00189	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—SST—Barrett's esophagus	0.000178	0.00188	CbGpPWpGaD
Trametinib—MAP2K2—Disease—SLC9A1—Barrett's esophagus	0.000168	0.00177	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—TP53—Barrett's esophagus	0.000168	0.00177	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—SST—Barrett's esophagus	0.000167	0.00176	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—PPARG—Barrett's esophagus	0.000162	0.0017	CbGpPWpGaD
Trametinib—MAP2K1—Disease—SLC9A1—Barrett's esophagus	0.000157	0.00166	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—GAST—Barrett's esophagus	0.000154	0.00162	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000152	0.0016	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—PPARG—Barrett's esophagus	0.000151	0.00159	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—GAST—Barrett's esophagus	0.000144	0.00152	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—RELA—Barrett's esophagus	0.000131	0.00138	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—RELA—Barrett's esophagus	0.000123	0.00129	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PTGES—Barrett's esophagus	0.000121	0.00128	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HGF—Barrett's esophagus	0.000116	0.00122	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—RELA—Barrett's esophagus	0.000116	0.00122	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HGF—Barrett's esophagus	0.000109	0.00114	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—RELA—Barrett's esophagus	0.000108	0.00114	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SST—Barrett's esophagus	0.000105	0.00111	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SST—Barrett's esophagus	9.86e-05	0.00104	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP26A1—Barrett's esophagus	9.2e-05	0.00097	CbGpPWpGaD
Trametinib—MAP2K2—Disease—APC—Barrett's esophagus	7.96e-05	0.000839	CbGpPWpGaD
Trametinib—MAP2K1—Disease—APC—Barrett's esophagus	7.45e-05	0.000785	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CXCL8—Barrett's esophagus	6.95e-05	0.000732	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	6.8e-05	0.000717	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—RELA—Barrett's esophagus	6.74e-05	0.00071	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SLC9A1—Barrett's esophagus	6.64e-05	0.000699	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PTGES—Barrett's esophagus	6.52e-05	0.000687	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CXCL8—Barrett's esophagus	6.5e-05	0.000685	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—RELA—Barrett's esophagus	6.3e-05	0.000664	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PTGS2—Barrett's esophagus	6.04e-05	0.000637	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PTGS2—Barrett's esophagus	5.65e-05	0.000596	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—APC—Barrett's esophagus	5.57e-05	0.000587	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	5.35e-05	0.000564	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APC—Barrett's esophagus	5.21e-05	0.000549	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	4.94e-05	0.000521	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—RELA—Barrett's esophagus	4.36e-05	0.000459	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CXCL8—Barrett's esophagus	4.1e-05	0.000432	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—RELA—Barrett's esophagus	4.07e-05	0.000429	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CXCL8—Barrett's esophagus	3.84e-05	0.000405	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	3.56e-05	0.000375	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PPARG—Barrett's esophagus	3.03e-05	0.000319	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TP53—Barrett's esophagus	2.52e-05	0.000265	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PTGS2—Barrett's esophagus	2.38e-05	0.000251	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TP53—Barrett's esophagus	2.36e-05	0.000248	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPARG—Barrett's esophagus	1.63e-05	0.000171	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	1.28e-05	0.000135	CbGpPWpGaD
